#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer limited stage Polyneuropathy Thrombotic microangiopathy Retinopathy of prematurity Endometrial adenocarcinoma Philadelphia chromosome positive Atypical haemolytic uraemic syndrome Colon cancer Rhabdoid tumour Autoimmune demyelinating disease Antiphospholipid syndrome Hereditary angioedema Herpes simplex Autoimmune haemolytic anaemia Pyruvate kinase deficiency anaemia More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Treatment Osteosarcoma recurrent – Trials in Disease Antisynthetase syndrome – Basic Information Splenic marginal zone lymphoma – Basic Information Mucopolysaccharidosis III – Trials in Disease Combined immunodeficiency – Trials in Disease Skin angiosarcoma – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Loeys-Dietz syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cabotegravir POLYMYXIN B SULFATE BRENSOCATIB Dalbavancin [18F]Fluoro-Peg-Folate Paclitaxel Obaluronate Lomustine ZOREVUNERSEN SODIUM Gfh925 Emactuzumab CARBOMER 980 Chlorpromazine Hydrochloride Coffee Charcoal Estradiol Hemihydrate Nusinersen Napabucasin ANTIMETABOLITES Revumenib Pyridoxine Cldn6 Car-T More therapies…

    Learn about Your Condition

    Hairy cell leukaemia Lupus nephritis Streptococcal infection Endotracheal intubation Psychogenic seizure Exposure via breast milk Follicular thyroid cancer External cephalic version Schizoaffective disorder Haemoptysis Chronic sinusitis Bladder cancer Hyperchylomicronaemia Non-small cell lung cancer Tinnitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal neoplasm
    • Fallopian tube cancer
    • Endometrial cancer
    Investigated Drugs:
    • Relacorilant
    • Bevacizumab
    • Paclitaxel Albumin-Bound
    Belgium France Germany Italy Poland Spain

  • Study of Tarlatamab for Patients with Metastatic or Advanced Small-Cell Lung Cancer and Neuroendocrine Carcinomas

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Tarlatamab
    France Germany

  • Study on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Vinorelbine
    • Allogeneic Faecal Microbiota, Pooled
    • Bevacizumab
    France

  • Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Budigalimab
    • Carboplatin
    • Cisplatin
    Belgium France Germany Italy Poland Romania +1

  • Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Pembrolizumab
    Belgium France

  • Study on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    France

  • Study of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Zilovertamab Vedotin
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    Belgium Denmark France Greece Hungary Italy +5

  • Study on Regorafenib with Cyclophosphamide, Capecitabine, and Aspirin for Patients with Metastatic Colorectal Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Bevacizumab
    • Capecitabine
    France

  • Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients 55+ with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Imatinib
    • Ponatinib
    • Blinatumomab
    Finland France Sweden

  • Study Comparing Ivonescimab to FOLFOX Drug Combination for Patients with Advanced Biliary Tract Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Ivonescimab
    • Calcium Folinate
    France
Previous Page
1 … 3 4 5 6 7 … 28
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!